MedTech Dive January 29, 2025
Susan Kelly

Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical coming to the U.S. market with robotic surgery systems.

After decades building the robotic surgery market, Intuitive Surgical will no longer have the field to itself in 2025.

Since gaining the first FDA clearance almost 25 years ago, da Vinci robots today are routinely used in numerous laparoscopic soft tissue procedures, including cardiac, urologic, gynecologic and general surgeries.

Now, dozens of newcomers are preparing to enter the arena, pursuing niches across the surgical landscape.

As the rollout of Intuitive Surgical’s da Vinci 5 system expands to a full launch later this year, the robotic surgery pioneer will continue to drive...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Health System / Hospital, Medical Devices, Provider, Robotics/RPA, Technology
What tariffs mean for the medical device industry - and who will pay for them?
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio

Share This Article